Cadila Healthcare has reported results for fourth quarter ended March 31, 2012.
The company has posted a rise of 55.30% in its net profit at Rs 139.40 crore for the quarter ended March 31, 2012 as compared to Rs 89.76 crore for the same quarter in the previous year. Total income has increased by 13.95% at Rs 795.86 crore for quarter under review as compared Rs 698.41 crore for the quarter ended March 31, 2011.
On the consolidated basis, the company has posted a fall of 4.52% in its net profit at Rs 170.88 crore for the quarter ended March 31, 2012 as compared to Rs 178.97 crore for the same quarter in the previous year. However, total income has increased by 16.34% at Rs 1415.58 crore for quarter under review as compared to Rs 1216.76 crore for the quarter ended March 31, 2011.
For the full year ended March 31, 2012, the company has posted a rise of 7.72% in its net profit at Rs 657.52 crore for the year ended March 31, 2012 as compared to Rs 610.38 crore for the same period in the previous year. Total income has increased by 13.82% at Rs 3389.92 crore for year under review as compared to Rs 2978.41 crore for the period ended March 31, 2011.
On the consolidated basis, the company has posted a fall of 8.22% in its net profit at Rs 652.59 crore for the year ended March 31, 2012 as compared to Rs 711.00 crore for the same period in the previous year. However, total income has increased by 14.49% at Rs 5316.46 crore for year under review as compared to Rs 4643.70 crore for the period ended March 31, 2011.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1505.20 |
Dr. Reddys Lab | 5922.45 |
Cipla | 1339.45 |
Zydus Lifesciences | 983.05 |
Lupin | 1609.85 |
View more.. |